BROSSARD, QUEBEC--(Marketwire - June 19, 2008) - DIAGNOS inc. ("DIAGNOS" or the "Corporation") (VENTURE TSX:ADK), a leader in the use of artificial intelligence ("AI") and advanced knowledge extraction techniques, was today named to the 2008 TSX Venture 50(TM), a ranking of Canada's top emerging public companies listed on TSX Venture Exchange.

"Being named to the TSX Venture 50 is a tremendous recognition for our accomplishments as a company. We work very hard, and are happy to have achieved this position. For the past seven years, our team has developed the DIAGNOS' AI (Artificial Intelligence) engine. It addresses multiple markets. We successfully launched our technology into the natural resources sector which continues to grow and contribute to our clients' successes. We have launched our FX platform that is attracting some of the largest players to our service and now we are moving forward with our cancer project in partnership with Queens University. So far, we have four vertical markets each producing revenues. The versatility of our product is leading us into more markets," said Andre Larente, Chairman and CEO of DIAGNOS.

The TSX Venture 50 are the top 10 companies in each of five major industry sectors (mining, oil & gas, technology & life sciences, diversified industries and cleantech), based on a ranking formula that includes revenue, return on investment, market cap growth, and trading volume.

"We are very proud to announce the 2008 TSX Venture 50 to celebrate the achievement of our issuers," said Kevan Cowan, President, TSX Venture Exchange. "The impressive list of companies demonstrates that the TSX Venture Exchange is a unique incubator for public companies, and the companies in the TSX Venture 50 are proof that this market is working."

The 2008 TSX Venture 50(TM) was compiled based on public historical data and is not an invitation to purchase securities listed on Toronto Stock Exchange and/or TSX Venture Exchange. TSX Group Inc. and its affiliates do not endorse or recommend any securities referenced in this ranking. Neither TSX Group Inc. nor its affiliated companies represent, warrant or guarantee the accuracy or the completeness of the information. You should not rely on the information contained in this news release for any trading, business or financial purposes. TSX Group Inc. and its affiliates assume no liability for any errors or inaccuracies in this news release or any use or reliance upon this information.

Andre Larente
DIAGNOS inc.
Chairman and CEO
450-678-8882, ext. 224
alarente@diagnos.com